Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.
Glycans of myelin proteins.
Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
Averting inflammation by targeting the cytokine environment.
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Evidence that nuclear factor IA inhibits repair after white matter injury.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
A nurse-led mental health service for people with multiple sclerosis.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Freedom from disease activity in multiple sclerosis.
Origin and evolution of deep brain stimulation.

Pages